Skip to main content

Day: February 10, 2022

mPhase Technologies Reports Record Fiscal 2022 Second Quarter Results – Trailing 12 Month Revenue Tops $32 Million

Gaithersburg, MD, Feb. 10, 2022 (GLOBE NEWSWIRE) — mPhase Technologies, Inc. (OTC Pink: XDSL) (“mPhase” or the “Company”), a technology company developing the mPower EV+ (electric vehicle) charging network and consumer engagement platform, today reported its financial results for its fiscal 2022 second quarter, ending December 31, 2021. Q2 marked the Company’s 11th straight quarter of year-over-year revenue growth. Fiscal 2022 Second Quarter Financial Highlights:● Revenue increased by 9.2% to a record $8.3 million compared to $7.6 million in the prior year quarter;   ● Gross profit margin increased 630 basis points to 32.6%, compared to 26.3% in the same year-ago quarter;   ● Operating income of $1.2 million showed a 10% year-over-year decrease, resulting in an operating margin of 14.2%;   ● The Company posted...

Continue reading

Nurix Therapeutics Announces Participation in the 11th Annual SVB Leerink Global Healthcare Conference

SAN FRANCISCO, Feb. 10, 2022 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a biopharmaceutical company developing targeted protein modulation drugs, today announced that Arthur T. Sands, M.D., Ph.D., Nurix’s president and chief executive officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17, 2022 at 3:40 PM ET. The event will be webcast live and may be accessed via a link in the Investors section of the Nurix website under Events and Presentations. An archived copy of the webcast will be available on the Nurix website for approximately 30 days after the event. About Nurix Therapeutics, Inc. Nurix Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapies...

Continue reading

Katapult Announces Appointments of Joyce Phillips and Jane J. Thompson to Board of Directors

New Directors bring decades of financial industry executive leadership to support Katapult’s next phase of growth PLANO, Texas, Feb. 10, 2022 (GLOBE NEWSWIRE) — Katapult, a lease-to-own platform that integrates with major e-commerce platforms to power online shopping for non-prime customers, today announced the appointment of Joyce Phillips and Jane J. Thompson to its Board of Directors, effective immediately. Ms. Phillips and Ms. Thompson were appointed to the class of directors that will stand for election at the 2022 Annual Meeting of Stockholders. “Both executives are accomplished business leaders and seasoned board members with an impressive record of achievement at the intersection of technology, finance, retail and banking,” said Orlando Zayas, CEO of Katapult. “Their fresh perspective will be an invaluable addition to our...

Continue reading

Inari Medical to Announce Fourth Quarter and Full-Year 2021 Financial Results

IRVINE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) — Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, announced today that it will release its fourth quarter and full-year financial results on Wednesday, February 23, 2022. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. Interested parties may access the live call via telephone by dialing (833) 519-1265 for domestic callers or (914) 800-3838 for international callers, using conference ID: 3126888. The live webinar may be accessed by visiting the Events Section of the Inari investor relations website at ir.inarimedical.com....

Continue reading

Monolithic Power Systems Announces Results for the Fourth Quarter and Year Ended December 31, 2021 and an Increase in Quarterly Cash Dividend

KIRKLAND, Wash., Feb. 10, 2022 (GLOBE NEWSWIRE) — Monolithic Power Systems, Inc. (“MPS”) (Nasdaq: MPWR), a global company that provides high-performance, semiconductor-based power electronics solutions, today announced financial results for the quarter and year ended December 31, 2021. The Company also announced that its Board of Directors has approved an increase in the quarterly cash dividend from $0.60 per share to $0.75 per share. The first quarter dividend of $0.75 per share will be paid on April 15, 2022 to all stockholders of record as of the close of business on March 31, 2022. The financial results for the quarter ended December 31, 2021 are as follows:Revenue was $336.5 million for the quarter ended December 31, 2021, a 4.0% increase from $323.5 million for the quarter ended September 30, 2021 and a 44.4%...

Continue reading

CareTrust REIT Sets Fourth Quarter Earnings Call for Thursday, February 17, 2022

SAN CLEMENTE, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) — CareTrust REIT, Inc. (NASDAQ:CTRE) announced today that it plans to release its fourth quarter and full year 2021 financial results after the U.S. markets close on Wednesday, February 16, 2022. Representatives of CareTrust REIT’s management team will host a conference call to discuss the results and other current matters the following day. Conference Call CareTrust REIT invites current and prospective investors to listen to the call on Thursday, February 17, 2022 at 1:00 p.m. Eastern Time (10:00 a.m. Pacific Time). The dial-in number is (844) 220-4972 (U.S./Canada) or (317) 973-4053 (International) and the conference ID number is 9255636. To listen to the call online as a webcast, or to view any financial or other statistical information required by SEC Regulation G, please...

Continue reading

Cytokinetics to Announce Fourth Quarter Results on February 24, 2022

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter results on February 24, 2022 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the company’s outlook for the future. The conference call will be simultaneously webcast and can be accessed from the homepage and in the Investors & Media section of Cytokinetics’ website at www.cytokinetics.com. The live audio of the conference call can also be accessed by telephone by dialing either (866) 999-CYTK (2985) (United States and Canada) or (706) 679-3078 (international) and typing in the passcode 2895984. An archived replay of the webcast...

Continue reading

First National Corporation Announces 17% Increase in Cash Dividend

STRASBURG, Va., Feb. 10, 2022 (GLOBE NEWSWIRE) — The Board of Directors of First National Corporation (Nasdaq: FXNC) declared a quarterly cash dividend of $0.14 per share on February 9, 2022. This was a 17% increase compared to the quarterly dividend paid on December 10, 2021. The dividend is payable on March 11, 2022 to shareholders of record as of February 25, 2022. ABOUT FIRST NATIONAL CORPORATION First National Corporation (NASDAQ: FXNC) is the parent company and bank holding company of First Bank, a community bank that first opened for business in 1907 in Strasburg, Virginia. The Bank offers loan and deposit products and services through its website, www.fbvirginia.com, its mobile banking platform, a network of ATMs located throughout its market area, a loan production office, a customer service center in a retirement community,...

Continue reading

Proactive news headlines including Empower Clinics, Kovo HealthTech, Thunderbird Entertainment, Cypress Development and Gungnir

New York , Feb. 10, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:Predictmedix highlights transformational growth and key achievements as it reviews 2021 click here  Canaccord Genuity happy with Silvercorp Metals 3Q results, citing strong margins, healthy balance sheet as catalysts for ‘Buy’ rating click here  ME2C Environmental wins new supply business at another Midwest plant operated by large utility customer click here  Empower Clinics strikes partnership with one of North America’s largest terminal operators to provide COVID-19 testing services click here  Thunderbird Entertainment appoints industry veteran Lana Castleman as its new marketing and communications director click here  Ridgeline...

Continue reading

Kevin G. Chavers and Luke S. Hayden to Join Freddie Mac Board of Directors

MCLEAN, Va., Feb. 10, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced that Kevin G. Chavers and Luke S. Hayden have been elected to its Board of Directors effective Feb. 15, 2022. Chavers retired as managing director, Global Fixed Income Investment Team, at BlackRock, Inc. in 2021, and Hayden has been chief executive officer of Hayden Consulting LLC since 2012. “Mr. Chavers brings additional mortgage finance, capital markets and public policy expertise to our Board. Over his more than two decades with some of the nation’s largest financial companies he has developed a deep familiarity with Freddie Mac and its leadership. Additionally, he possesses hands-on experience as an innovator and issuer of agency mortgage-backed securities,” said Sara Mathew, non-executive chair of Freddie Mac’s Board of Directors. “Mr....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.